Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,128 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05268887Recruiting
Light, sound, and touch therapy for Parkinson’s symptoms
This trial tests whether high-frequency light, sound, and gentle touch can improve movement and thinking problems in people with Parkinson’s disease. You may help the researchers learn if this kind of stimulation is safe and beneficial alongside your usual Parkinson’s medications.
Cambridge, MassachusettsAges 45–90 - NCT05275335Recruiting
Study how germs in burn wounds are best identified
This study compares two ways of finding germs (microbes) in burn wounds: traditional tissue swabs/cultures versus a newer DNA-based method. It may help improve how clinicians understand burn infections and tailor care.
Galveston, TexasAges 18–100 - NCT05297734Recruiting
Study compares two cancer support care plans
This study tests two different ways of providing supportive care for adults with cancer to see which one works better. It may help improve comfort, support, and care coordination during treatment.
Birmingham, AlabamaAges 18 years+ - NCT05300464Recruiting
Test MammoWave for finding breast lesions on imaging
This study checks how well MammoWave can help detect breast lesions (areas that may be abnormal) using imaging. It may help doctors confirm findings by combining it with other scans when needed, and sometimes with biopsy results.
Genova, GenovaAges 18 years+ - NCT05321134Recruiting
Testing single-port robot surgery for colorectal conditions
This study checks how well a newer single-opening (single-port) robot works for colorectal surgery. It may help surgeons perform operations with the robotic system in carefully selected colorectal conditions.
Sacramento, CaliforniaAges 18 years+ - NCT05322837Recruiting
Tracking arm nerve and strength recovery after first stroke
This study follows how stroke survivors’ arm feeling (sensory) and movement (motor) recover over time. It may help clinicians better understand recovery patterns in Asian patients and improve rehabilitation support.
SingaporeAges 21–90 - NCT05323916Recruiting
Intensive rehab program after a first stroke
This trial tests whether an intensive, day-long rehabilitation program can improve recovery after a first ischemic stroke. It focuses on people with mild to moderate disability who can safely handle several hours of therapy each day.
PragueAges 18–85 - NCT05326243RecruitingPhase 1/Phase 2
CAR-T therapy for hard-to-treat B-cell lymphoma
This trial tests a CAR-T cell treatment made to target CD19 on lymphoma cells (PL001). It’s for people whose B-cell lymphoma has come back or not responded to standard treatments, aiming to shrink the cancer and help control the disease.
Taipei, TaiwanAges 14 years+ - NCT05372484Recruiting
Test technology to improve cervical cancer screening and diagnosis
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
Houston, TexasAges 25–49 - NCT05377307Recruiting
Long-term follow-up for gene-edited immune cell therapy
This study checks how people are doing years after receiving a specific company’s gene-edited immune cell treatment. It helps researchers learn about long-term safety and health outcomes.
Kaohsiung, TaiwanAges Any age - NCT05424172Recruiting
Smartphone coaching to boost exercise after spinal cord injury
This study tests a smartphone program and coaching to help people with spinal cord injury follow recommended exercise routines. It may help you increase how much you exercise and improve adherence to exercise guidelines.
Chicago, IllinoisAges 18–80 - NCT05426135Recruiting
AI tool to assess cancer risk and guide care
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Wuhan, HubeiAges 18–75 - NCT05434507Recruiting
Clip procedure for leaking tricuspid valve in high-risk patients
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
Shanghai, Shanghai MunicipalityAges 60–90 - NCT05439226Recruiting
Diet plan targeting liver fat for type 2 diabetes
This study tests whether a Chinese medical nutrition therapy diet can reduce liver fat and help manage type 2 diabetes in people who also have fatty liver. You may be asked to follow a specific eating plan and keep your diabetes care stable during the study.
Yichang, HubeiAges 18–75 - NCT05445011RecruitingPhase 1
FLT3-targeted CAR-T for relapsed or resistant AML
This trial tests an engineered immune cell treatment (CAR-T) made to target FLT3, for adults with acute myeloid leukemia (AML) that has come back or did not respond to standard treatment. It aims to control the leukemia when options have been limited.
Wuhan, HubeiAges 18–70 - NCT05445583Recruiting
Technology support program for young adults with uncontrolled asthma
This study tests whether a technology-based program can help improve asthma control in young African American adults who are not currently well controlled. It may help you track symptoms and use asthma tools more consistently between clinic visits.
Tallahassee, FloridaAges 18–30 - NCT05448833Recruiting
Testing a wireless sensor to monitor left heart pressure
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
Petah TikvaAges 22–88 - NCT05448703Recruiting
Predicting radiation lung injury after lung cancer treatment
This study looks at ways to predict who will develop radiation pneumonitis (lung inflammation after radiation) and how outcomes vary. It may help doctors better watch and treat lung side effects after lung cancer radiation.
Wuhan, HubeiAges 18 years+ - NCT05479461Recruiting
Phone-based blood pressure care vs usual care
This trial tests whether a technology-enabled program (using a smartphone) helps lower blood pressure better than standard care. It may help you manage high blood pressure with guided treatment changes.
Palo Alto, CaliforniaAges 30–90 - NCT05495139Recruiting
Gastric bypass stent study for fatty liver disease
This small study tests whether placing a gastric bypass stent can improve nonalcoholic fatty liver disease (fatty liver not caused by heavy alcohol). You may be considered if your liver fat is high on a special MRI scan and you meet several safety and medical history rules.
ShanghaiAges 18–65 - NCT05530096Recruiting
Genetic test to find minimal residual myeloma in remission
This study tests a genetic technology (ClonoSeq-based) to detect very small amounts of multiple myeloma that may remain after treatment. It may help doctors better track how well treatment is working and predict how the disease responds over time.
Montreal, QuebecAges 18 years+ - NCT05532943RecruitingPhase 1/Phase 2
Cord stem cell treatment for people with multiple sclerosis
This Phase 1/2 trial studies whether donated umbilical cord stem cells are safe and can improve multiple sclerosis. It aims to see if the treatment is workable for people who still have active MS despite standard therapies.
Taichung, Non-USAges 20–65 - NCT05561842Recruiting
Mobile ultrasound tablet test for breast cancer diagnosis in Nigeria
This study tests a tablet-based ultrasound (a scan using sound waves) to help identify breast lumps that look like cancer. If your lump looks suspicious, the scan result is intended to guide next steps like biopsy or surgical removal at the hospital.
New York, New YorkAges 18 years+ - NCT05578495Recruiting
Track daily movement to predict future health problems
This study looks at how active versus sedentary you are (often using a digital signature from your daily routine) to see how it relates to developing multiple health conditions over time. It may help researchers understand which activity patterns are linked with higher risk, especially in certain long-term illnesses.
Clermont-FerrandAges 18–90
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,128 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.